Neuphoria Therapeutics Inc. (NEUP) Financials
NEUP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 34.8 million | 5.4 million |
| Dec. 31, 2025 | 36.6 million | 6.9 million |
| Sept. 30, 2025 | 27.3 million | 14.8 million |
| June 30, 2025 | 43.4 million | 14.6 million |
NEUP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.9 million | 70286 |
| Dec. 31, 2025 | -6.4 million | 93701 |
| Sept. 30, 2025 | -3.8 million | 111277 |
| June 30, 2025 | 73.6 million | 163.7 million |
NEUP Net Income
No data available :(
NEUP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 19.4 million | - | - |
| Dec. 31, 2025 | 22.2 million | - | - |
| Sept. 30, 2025 | 13.6 million | - | 85210 |
| June 30, 2025 | 21.6 million | - | 176727 |
NEUP Shares Outstanding
NEUP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 2 | -752550 | 2.5 million | - |
| Dec. 31, 2025 | - | 1.0 million | 3.2 million | - |
| Sept. 30, 2025 | 2 | 5.7 million | 2.8 million | - |
| June 30, 2025 | 3 | 700570 | -1.3 million | - |
NEUP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 165695 |
| Dec. 31, 2025 | - | 165789 |
| Sept. 30, 2025 | - | 250826 |
| June 30, 2025 | -10.5 million | 331144 |
NEUP
Price: $4.31
52 week price:
Earnings Per Share: -7.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 25.0 million